FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals Spironolactone Tablets Recall

Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured…

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals · Burbank, CA

Risk level
Class II
Reported by FDA
Mar 24, 2021
Recall ID
D-0304-2021
Check your lot numberHow we source this data

Summary

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals recalled Spironolactone Tablets starting Jan 27, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0304-2021 on Mar 24, 2021. Reason: Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets. Status: Ongoing.

Why it was recalled

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.

Product description

Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01

Lot numbers, UPCs & expiration codes

Lot #: 148992, Exp 5/31/2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0304-2021
Classification
Class II
Status
Ongoing
Recall initiated
Jan 27, 2021
FDA report date
Mar 24, 2021
Quantity
12 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0304-2021, exactly as published.

Show all FDA fields
City
Burbank
State
CA
Status
Ongoing
Country
United States
Event ID
87283
Address
1919 N Victory Pl
Code information
Lot #: 148992, Exp 5/31/2022
Postal code
91504-3425
Report date
Mar 24, 2021
Product type
Drugs
Recall number
D-0304-2021
Classification
Class II
Recalling firm
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals
Product quantity
12 bottles
Reason for recall
Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 27, 2021
Initial firm notification
E-Mail
Center classification date
Mar 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0304-2021, published Mar 24, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls